Fabian Gerlinghaus, Cellares CEO and president Omar Kurdi at the company's facility in South San Francisco

Ex­clu­sive: Cel­lares ex­pands deal with Bris­tol My­ers on CAR-T as­set, eyes man­u­fac­tur­ing ex­pan­sion

Cel­lares has ex­pand­ed its part­ner­ship deal with Bris­tol My­ers Squibb to as­sist the Big Phar­ma in de­vel­op­ing an­oth­er un­named CAR-T cell ther­a­py via its cell …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.